|
|
 |
|
Viewing report
|
|
|
|
Protease Inhibitors in AIDS Therapy
Informa Healthcare, Jan 2001, Pages: 328
Details the evolution of HIV protease inhibitors from molecular development through medical applications!
Considering the latest class of revolutionary drugs fighting against HIV infection and AIDS, this comprehensive reference thoroughly examines the development and properties of HIV protease inhibitors from clinical and scientific perspectives, discussing how protease inhibitors changed the FDA approval process-enhancing the collaboration between regulatory authorities and drug developers.
Spotlights protease inhibitors as the cornerstone drugs of the first HAART regimens-key components of long-term viral suppression and immune restoration, and in secondary and tertiary regimens!
Evaluating protease inhibitors as therapeutic options and research tools, Protease Inhibitors in AIDS Therapy
- reviews the impact of advances in recombinant DNA technology for understanding and treating HIV and AIDS
- highlights a variety of strategies and techniques for drug discovery and development illustrated by success stories of pharmaceutical companies and biotechnology start-up firms
- summarizes the pharmacokinetics, metabolism, and drug interactions of protease inhibitors
- details preliminary clinical studies on oral bioavailability, pharmacokinetic profiling, efficacy, resistance, and tolerability
- describes available efficacy data for marketed inhibitors and those in clinical development
- reports on efforts to manage antiviral resistance in the clinic and improve patient adherence to complex drug therapy
- and more!
Containing more than 600 helpful literature references, drawings, photographs, and tables, Protease Inhibitors in AIDS Therapy serves for an essential reference for infectious disease specialists, epidemiologists, virologists, immunologists, pharmacologists, medicinal chemists and biochemists, microbiologists, hematologists, hepatologists, and medical students in these disciplines.
Customers who bought this item also bought
HIV-1 Integrase: Mechanism and Inhibitor Design
Aspartic Acid Proteases as Therapeutic Targets
Emerging Microbiology Tests and Companies Developing New Technologies and Products
Advanced Therapy for Hepatitis C
The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine
Therapeutic Strategies in Schizophrenia
Textbook of Diabetes, 4th Edition
The Medical Management of HIV/AIDS
Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011
2012 France Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies
|
|
|
|
